Identification of the hub genes RUNX2 and FN1 in gastric cancer

Chao Han(Zhejiang Chinese Medical University), Zhongtao Zhang(Capital Medical University)
Open Medicine
January 1, 2020
10.1515/med-2020-0405
Cited by 14

Related Papers

Perioperative or postoperative adjuvant oxaliplatin with S-1 versus adjuvant oxaliplatin with capecitabine in patients with locally advanced gastric or gastro-oesophageal junction adenocarcinoma undergoing D2 gastrectomy (RESOLVE): an open-label, superiority and non-inferiority, phase 3 randomised controlled trial
|The Lancet Oncology|2021|436
Short-term outcomes of complete mesocolic excision versus D2 dissection in patients undergoing laparoscopic colectomy for right colon cancer (RELARC): a randomised, controlled, phase 3, superiority trial
|The Lancet Oncology|2021|184
A Multicenter Study on Etiology of Acute Pancreatitis in Beijing During 5 Years
|Pancreas|2014|147
Short-term surgical outcomes of laparoscopy-assisted versus open D2 distal gastrectomy for locally advanced gastric cancer in North China: a multicenter randomized controlled trial
|Surgical Endoscopy|2018|100
Percutaneous Intramyocardial Septal Radiofrequency Ablation in Patients With Drug-Refractory Hypertrophic Obstructive Cardiomyopathy
|JAMA Cardiology|2022|98